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Abstract
For more than 150 years it is known that occupational overexposure of manganese (Mn) causes 
movement disorders resembling Parkinson’s disease (PD) and PD-like syndromes. However, the 
mechanisms of Mn toxicity are still poorly understood. Here, we demonstrate that Mn dose- and 
time-dependently blocks the protein translation of amyloid precursor protein (APP) and heavy-
chain Ferritin (H-Ferritin), both iron homeostatic proteins with neuroprotective features. APP and 
H-Ferritin are post-transcriptionally regulated by iron responsive proteins (IRPs), which bind to 
homologous iron responsive elements (IREs) located in the 5’-untranslated regions (5’-UTRs) 
within their mRNA transcripts. Using reporter assays, we demonstrate that Mn exposure repressed 
the 5’-UTR-activity of APP and H-Ferritin, presumably via increased IRP-IRE binding, ultimately 
blocking their protein translation. Using two specific Fe2+-specific probes (RhoNox-1 and IP-1) 
and ion chromatography inductively coupled plasma mass spectrometry (IC-ICP-MS), we show 
that loss of the protective axis of APP and H-Ferritin resulted in unchecked accumulation of 
redox-active ferrous iron (Fe2+) fueling neurotoxic oxidative stress. Enforced APP expression 
partially attenuated Mn-induced generation of cellular and lipid reactive oxygen species (ROS) 
and neurotoxicity. Lastly, we could validate the Mn-mediated suppression of APP and H-Ferritin 
in two rodent in vivo models (C57BL6/N mice and RjHan:SD rats) mimicking acute and chronic 
Mn exposure. Together, these results suggest that Mn-induced neurotoxicity is partly attributable 
to the translational inhibition of APP and H-Ferritin resulting in impaired iron metabolism and 
exacerbated neurotoxic oxidative stress.
Graphical abstract
For more than 150 years it is known that occupational overexposure of manganese (Mn) causes 
movement disorders resembling Parkinson’s disease (PD) and PD-like syndromes. Here we 
demonstrate that Mn exposure results in suppression of amyloid precursor protein (APP) and H-
Ferritin in vitro and in vivo. On the molecular level, it could be shown that Mn inhibits the protein 
translation via repressing the 5’-UTR activity of both proteins. Mn-mediated suppression of both 
iron-regulating proteins results in an accumulation of redox-active iron (Fe2+) that fuels neurotoxic 
cellular oxidative stress and lipidperoxidation. APP overexpression significantly attenuate Mn-
induced oxidative stress and neurotoxicity. The implications that Mn exposure results in a 
translational suppression of APP and H-Ferritin links a disturbed iron homeostasis with Mn-
induced oxidative neurotoxicity
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INTRODUCTION
The essential trace element and transition metal manganese (Mn) plays an important role as 
vital co-factor in receptors, transporters and many enzymatic reactions, including the anti-
oxidant enzyme Mn-superoxide dismutase (MnSOD). At physiological levels, Mn is 
required for wound-healing, bone and cartilage formation, mitochondrial function and 
energy production. Thus, a balanced Mn homeostasis is crucial for cell maintenance and 
viability (Peres et al. 2016, Farina et al. 2013).
However, Mn has also been documented as a potent neurotoxic agent for about 150 years 
(Dobson et al. 2004, Farina et al. 2013). Excessive or prolonged exposure cause irreversible 
damage to the nervous system, in particular to the iron-rich basal ganglia resulting in the 
development of “manganism”, a neurological disorder with symptoms such as bradykinesia 
and rigidity resembling Parkinson’s disease (PD) and PD-like disturbances (Pal et al. 1999, 
Chia et al. 1993, Guilarte 2013, Gorell et al. 1997). Furthermore, the PD-linked gene 
ATP13A2 (also known as PARK9) is strikingly implicated in neuronal detoxification of Mn 
as well as suppressing α-synuclein toxicity (Gitler et al. 2009, Tan et al. 2011). In addition, 
newly identified loss-of-function mutations in the Mn efflux transporter gene SLC30A10 are 
linked to PD-like symptoms, altogether underscoring the biological complexity of these 
multifactorial neurodegenerative disorders (Quadri et al. 2012, Tuschl et al. 2012).
A body of evidence suggests that Mn-driven neurotoxicity is associated with altered iron 
metabolism, both systemically and at the cellular level due to similar physiochemical 
properties and shared absorptive pathways, such as the divalent metal transporter (DMT1) 
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that competitively regulates the uptake Mn and iron (Chua & Morgan 1996, Kwik-Uribe et 
al. 2003, Gunshin et al. 1997). Despite these similarities there are also some essential 
differences between both transition metals. Common oxidation states of Mn are 2+, 3+, 4+, 
6+ and 7+, with Mn2+ (later referred to as Mn) being the most stable oxidation state (Farina 
et al. 2013). Within biological systems, iron occurs in one of two oxidation states known as 
ferrous (Fe2+) and ferric iron (Fe3+). While Fe3+ is redox-inactive, Fe2+ is an intrinsic 
generator of reactive oxygen species (ROS) by catalyzing the decomposition of H2O2 
producing highly toxic hydroxyl radicals and membrane lipidperoxidation via Haber-Weiss 
and Fenton reactions (Kehrer 2000, Gaschler & Stockwell 2017). Both, increased production 
of cellular ROS and peroxidized phospholipids corrupt the integrity of proteins, lipids and 
DNA, which can result in detrimental consequences on core cellular functions (Sies 2015) 
and even trigger a programmed necrotic cell death, known as “ferroptosis” (Dixon et al. 
2012, Stockwell et al. 2017). In contrast, unlike Fe2+, Mn is not capable to generate such 
hydroxyl radicals via Haber-Weiss or Fenton reaction like (Archibald & Tyree 1987). 
However, Mn-catalyzed auto-oxidation of dopamine involves redox-cycling of Mn3+ and 
Mn2+ in a reaction that can result in ROS and dopamine-o-quinone generation, both fueling 
oxidative stress (Segura-Aguilar & Lind 1989). We and others previously demonstrated that 
Mn exposure results in a shift of Fe2+/Fe3+ ratio towards redox active Fe2+ accompanied by 
depleted levels of the antioxidant glutathione and increased oxidative stress markers in vitro 
and in vivo (Fernsebner et al. 2014, Kwik-Uribe et al. 2003, Neth et al. 2015). However, the 
molecular basis of the Mn-induced iron-shift and redox-alteration remains to be elucidated.
To avoid cellular accumulation of free toxic Fe2+, iron metabolism requires the tight 
coordination of a wide variety of genes that are primarily controlled through post-
transcriptional regulatory mechanisms, including the iron storage protein ferritin (light-chain 
(L-Ferritin) and the heavy-chain type (H-Ferritin)), iron importer transferrin receptor 1 
(TFR1) and iron exporter ferroportin (FPN) (Bogdan et al. 2016). All such iron homeostasis 
proteins contain iron-responsive elements (IRE) in their respective mRNAs located within 
the 5’- or 3’-untranslated regions (UTRs) flanking their coding sequences. Binding of iron 
regulatory proteins (IRP1 and IRP2) to IRE-sequences on 5’- and 3’-UTRs have opposite 
effects on target mRNA expression (Anderson et al. 2012, Hentze et al. 2010): While IRP 
binding to 3’-UTR IREs enhances mRNA stability that results in increased protein 
expression, IRP binding to 5’-UTR IREs blocks the translation of iron-responsive target 
genes. In this context, we previously identified a fully functional IRE-like RNA stem loop in 
the 5’-UTR of the amyloid precursor protein (APP) (Rogers et al. 2002). Consistently, we 
showed that genetic deletion of IRP1 facilitates translational activation of APP mRNA, 
ultimately increasing its protein expression (Cho et al. 2010).
APP is a ubiquitously expressed type-I-transmembrane protein that is known to contain 
copper and zinc-binding domains (Bayer et al. 1999). Pathological APP processing by β- 
and γ-secretases, generating neurotoxic Aβ-peptides, is believed to be the key event in the 
pathogenic cascade in Alzheimer’s disease (AD) (Selkoe 2001). However, under 
physiological conditions, APP is predominantly processed in a non-amyloidogenic manner 
via α-secretase that precludes Aβ production and releases the large N-terminal fragment 
sAPPα (Sisodia 1992). Compared to the neurotoxic properties of Aβ peptides (Haass & 
Selkoe 2007), sAPPα possesses cell protective and growth-promoting features that have 
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been validated both in vitro and in vivo , including neuronal and multiple cancer cell lines as 
well as several animal models (Venkataramani et al. 2010, Venkataramani et al. 2012, Zheng 
& Koo 2011, Müller et al. 2017). Intriguingly, we and others recently elucidated that APP 
and sAPPα indirectly facilitate iron efflux via stabilizing the key Fe2+-exporter FPN (Duce 
et al. 2010, Wong et al. 2014, McCarthy et al. 2014). Consistent with this, we demonstrated 
a significant accumulation of total and labile iron pool in APP−/− mice that was 
accompanied with a marked induction of oxidative stress levels in the brain and other organs 
compared to wild-type mice (Duce et al. 2010, Ayton et al. 2015).
Given the role and functions of APP and H-Ferritin in orchestrating iron homeostasis and 
responses, we here investigated if Mn interferes with the translational control of both 
proteins resulting in blocked iron efflux and depleted iron storage in neuronal-like SH-SY5Y 
cells and in two different rodent in vivo models.
MATERIALS AND METHODS
Reagents and antibodies:
Manganese-(II)-chloride tetrahydrate (MnCl2·4H2O, cat no.: M3634) and Manganese-(II)-
acetate (cat no.: 330825) (both referred as Mn), ferric ammonium citrate (FAC, cat no.: 
F5879), desferrioxamine mesylate salt (DFO, cat no.: D9533) and 3-Hydroxy-1,2-
dimethyl-4(1H)-pyridone (Deferiprone, DEF, cat no.: 379409) were purchased from Sigma-
Aldrich (St. Louis, MO). Calcein-AM (calcein-acetoxymethyl ester, cat no.: C3100MP) was 
purchased from Thermo Fisher Scientific. Stocks of FAC (10 mM), Mn (100 mM), DFO (10 
mM) and DEF (100 mM) were prepared in DMEM and purified water, respectively. The 
following antibodies were used: IRP1 (EPR7225, cat no.: ab126595, abcam), IRP2 (IREB2, 
cat no.: PA1–16544, Thermo Fisher Scientific), β-actin (C-11, cat no.: A2066, Sigma-
Aldrich and AC-15, cat no.: ab6276, abcam), anti-FTH1 (H-Ferritin) antibodies (D1D4, cat 
no.: #4393, Cell Signaling and cat no.: ab137758, abcam), LC3B (D11, cat no.: #3868) and 
Beclin-1 (D40C5, cat no.: #3495) (both Cell signaling). For APP detection we used the c-
terminal APP antibody (cat no.: A8717, Sigma-Aldrich) and the N-terminal APP antibody 
(22C11, cat no.: MAB348, Millipore).
Cell culture and transfection:
The human neuroblastoma cell line SH-SY5Y (RRID: CVCL_0019) was initially purchased 
from ATCC. This cell line is not listed as a commonly misidentified cell line by the 
International Cell Line Authentication Committee (ICLAC; http://iclac.org/databases/cross-
contaminations/). We have confirmed in this cell line the heterozygous ALK p.F1174L 
mutation by Sanger sequencing. Stably expressing cell lines overexpressing human wildtype 
APP695 isoform (SH-SY5Y APP695) or empty vector (pCEP4) were previously established 
(Venkataramani et al. 2010). The stable SH-SY5Y cell line transfected with the APP 5’-UTR 
luciferase or HIRE_CAT constructs were described previously (Rogers et al. 2016, Thomson 
et al. 2005).
Immortalized APP−/− MEFs and corresponding wild-type MEFs (APP+/+) were provided by 
Ulrike Müller (University Heidelberg) and described previously (Li et al. 1996). All cell 
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lines were cultured in DMEM (Dulbecco’s modified Eagle’s medium) supplemented with 
10% (v/v) fetal calf serum, 1% L-glutamine and 1% penicillin/streptomycin. Complete 
medium were changed every 2–3 days.
Protein extracts and Western blot analyses:
Cells at 60-70% confluency were treated with indicated conditions and time points. After 
subsequent washing in PBS, cells were scraped into modified radioimmunoprecipitation 
assay (RIPA) lysis buffer (PBS pH 7.4, 0.5% sodium deoxycholate, 1% NP-40) on ice for 30 
min with gentle agitation. Cell lysates were centrifuged at 10,000 × g for 10 min. Mice and 
rat whole brains were collected in cold PBS on ice. For all mice experiments cortex tissue 
(frontal cortex) were isolated, fully homogenized in RIPA buffer (Solarbio, cat no.: R0020). 
For all shown rat experiments, whole brain tissues were lysed in ice cold extraction buffer 
(10 mM Tris-HCl, pH 7.4, previously purged with helium for 3 h) as previously published 
(Fernsebner et al. 2014). Total protein concentrations were analyzed using DC protein assay 
(cat no.: 500-0113, Bio-Rad). Unless stated otherwise, cell extracts (15-20 µg/well) were 
separated by SDS-PAGE at 100V constant using Mini-PROTEAN TGX precast 4-15% 
gradient gels (cat no.: 456-1085, Bio-Rad) and transferred using the Bio-Rad nitrocellulose 
and Trans-Blot Turbo System. Unless stated otherwise, western blots from three independent 
experiments were quantified using ImageJ software (version 1.41o, National Institutes of 
Health). Images were captures using a CCD camera. To enhance visibility of bands, images 
were equally adjusted for contrast in Adobe Photoshop. If comparisons are to be made 
between images, the blots were taken with identical conditions and manipulated equally.
Quantitative Real-Time-PCR analysis:
Total RNA was isolated using TRI-reagent (cat no.: T9424, Sigma-Aldrich) according to the 
manufacturer’s instructions. Assays were performed using an ABI Prism 7000 system 
(Applied Biosystems, Foster City). APP primers (forward, 5-
GCCCTGCGGAATTGACAAG-3; reverse, 5-CCATCTGCATAGTCTGTGTCTG-3), 
ferroportin primers (forward, 5-CTACTTGGGGAGATCGGATGT-3; reverse, 5-
CTGGGCCACTTTAAGTCTAGC-3), ferritin primers (forward, 5-
CCCCCATTTGTGTGACTTCAT-3; reverse, 5-GCCCGAGGCTTAGCTTTCATT-3); 
transferrin receptor primers (forward, 5-GGCTACTTGGGCTATTGTAAAGG-3; reverse, 5-
CAGTTTCTCCGACAACTTTCTCT-3); and β-actin primers (forward, 5-
CATGTACGTTGCTATCCAGGC-3; reverse, 5-CTCCTTAATGTCACGCACGAT-3) were 
purchased from Life Technology.
Quantification of luciferase (luc) and chloramphenicol acetyltransferase (CAT) activity:
Luciferase Assay Kit (cat no.: E1500, Promega) was used according to manufacturer’s 
directions to measure the luciferase activity. Reporter assays for balanced luciferase assays 
using the transfectants encoding the APP 5’-UTR luciferase (luc) reporter construct pGAL 
were as described previously (Rogers et al. 2016). The activity of the Ferritin-H chain 
specific iron-responsive element (H-Ferritin IRE) was assessed using the plasmid construct, 
designated as HIRE_CAT, in which the H-Ferritin IRE had been ligated in front of a 
chloramphenicol acetyltransferase (CAT) reporter gene. CAT enzyme-linked immunosorbent 
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assays were performed according to manufacturer’s instructions (Roche Applied Science) as 
previously described (Thomson et al. 2005).
Cell Viability and cell number quantification:
Cell viability was measured by a colorimetric assay either by using the MTT (thiazolyl blue 
tetrazolium, Sigma-Aldrich) viability assay or the MTS-Assay (CellTiter96 AQassay, cat 
no.: G3582, Promega) according to the protocol of the supplier (Venkataramani et al. 2010). 
Cell viability data are presented as relative changes in % compared to untreated controls. In 
parallel, cells were grown in 12-well plates for cell number analysis. Repetitive aliquots 
were taken and counted using a hemocytometer with trypan blue exclusion assay. For each 
treatment condition, triplicate wells were counted, and values were averaged. Data were 
presented as relative values in % compared to untreated controls.
Quantification of the labile iron pool (LIP):
Increasing Mn concentrations were incubated with SH-SY5Y cells or complete DMEM 
media alone using isoplate 96 well plates (Perkin Elmer). Cells or media alone were loaded 
with calcein-AM at a final concentration of 0.25 µM. Fluorescence (Excitation/Emission: 
485/520 nm) was assessed using the FlexStation3 multi-mode microplate reader (Molecular 
Devices). Background fluorescence was subtracted and data was expressed as mean ± SEM 
from 6 replicates.
Fe2+-specific probes Rho-Nox1 and IP-1 were prepared by Allegra Aron, Ho Yu Au-Yeung 
and Christopher J. Chang (Department of Chemistry, University of California, Berkeley) and 
freshly dissolved in DMSO at a stock concentration of 2 mM (Niwa et al. 2014, Au-Yeung 
et al. 2013). Cells were incubated with DMEM media alone or increasing Mn doses for 24 h, 
washed with PBS and loaded with 5 µM RhoNox-1 dissolved in OptiMEM media for 60 
min. After incubation, cells were washed once with PBS. As positive control, cells treated 
for 24 h with Mn were washed with PBS and incubated with 100 µM DEF for 1 h and 
washed again with PBS. Fluorescence (Excitation/Emission: 540/575 nm) was analyzed 
using a TECAN reader. In a similar fashion, cells were incubated with a 20 µM final 
concentration of IP-1 dissolved in OptiMEM media for 2 h. Cells were washed with PBS 
and fluorescence (Excitation/Emission: 488/550 nm) was analyzed using a TECAN reader.
Quantification of Fe2+, Fe3+ and Mn2+ using IC-ICP-sf-MS and CE-ICP-qMS analysis:
Speciation and quantification of Fe2+, Fe3+ and Mn2+ was performed by ion 
chromatography inductively coupled plasma mass spectrometry (IC-ICP-MS) as described 
previously (Fernsebner et al. 2014, Solovyev et al. 2017) and in addition with capillary 
electrophoresis inductively coupled plasma mass spectrometry (CE-ICP-MS). For redox 
speciation of Fe2+ vs. Fe3+ the IC-ICP-MS method used a Thermo-Dionex guard column 
IonPac™ CG5A column and an IonPac™ CS5A RFIC 4*250 mm analytical column, 
directly hyphenated to high-resolution sectorfield ICP-sf-MS (Element II, Thermo 
Scientific). Experimental conditions were analogous to (Solovyev et al. 2017): Redox 
species were separated isocratically using an eluent consisting of 50 mM ammonium citrate, 
7mM dipycollinic acid (PDCA), pH 4.2 at a flow rate of 0.8 ml/min. Detection was 
performed on 56Fe isotope at the ICP-sf-MS in medium resolution mode. For cross-
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validation a coupling of capillary electrophoresis (PrinCe 760, Prince Technologies) with 
ICP-qMS (NexIon 360 M, Perkin Elmer) was employed. The CE-ICP-MS method operated 
in positive electrophoretic mode at acidic pH (background electrolyte: 20 mM HCl, +25 
kV). Monitored isotopes were 55Mn, 56Fe and 57Fe, using DRC cell technology with 
ammonia as DRC gas in accordance to (Quintana et al. 2006) for removing of interferences 
at respective isotopes.
Determination of cytoplasmic and lipid reactive oxygen species (ROS):
For detection of cytoplasmic ROS, cells were seeded in 6-well plates at a density of 1×105 
cells in full media. After 24 h Mn treatment, cells were washed twice in PBS and 
subsequently incubated with a 25 µM working solution of H2DCFDA (cat no.: D399, 
Molecular Probes, Stock 20 mM dissolved in methanol) for 10 min light-protected at 37°C. 
After brief washing with PBS, fluorescence was analyzed via FACS (FL-1 channel). For 
detection of lipid peroxidation (Lipid-ROS), cells were incubated with a 10 µM working 
solution of BODIPY 581/591 C11 (cat no.: D3861, Molecular Probes, Stock 2 mM in 
DMSO) and incubated for 45 min light-protected at 37°C. Lipid-ROS was analyzed via flow 
cytometry (excitation at 488 nm and emission at 530 (FL-1)) and (excitation at 488 nm and 
emission at 585 nm (FL-2)). Data were analyzed by FlowJo software and presented as 
relative induced ROS compared to untreated controls. For Lipid-ROS the fluorescence ratio 
FL1/FL2 reflecting the oxidation of the probe were presented either in arbitrary units or as 
relative induced lipid ROS compared to untreated controls.
Rodent experiments and treatments:
All mice were housed in a specific pathogen-free facility and maintained on a purified 
AIN-76A diet (Research Diets, New Brunswick, NJ, USA). All mice were maintained under 
a 12-hour light/dark cycle, controlled temperature (22 ± 2°C) and humidity (65 ± 5%). Eight 
weeks male mice with C57BL6/N background (C57BL/6NCrl, Charles Rivers) were housed 
in cages for 5 days before the experiment. The mice (~21.3 – 25.1 g body weight) were 
randomly divided into four groups by body weight stratification (n=5 for each group): Mice 
were either fed with standard diet (control group: Mn 10 ppm, diet D08080401) or high Mn 
diet (Mn group: 2400 ppm, diet D17020702, both from Research Diets, New Brunswick, NJ, 
USA) for 91 days. Furthermore, mice were intraperitoneally (i.p.) injected with either PBS 
(calcium and magnesium free PBS, control group) or MnCl2 (MnCl2·4H2O, Mn group: 40 
mg/kg body weight/day) for 7 days. No calculations to predetermine sample size of each 
group was needed. At the end of each experiment, all mice were sacrificed by anesthesia 
with chloral hydrate to reduce the pain of animals during the process. All mice experiments 
were approved by the Institutional Animal Care and Use Committee of Zhengzhou 
University.
All showed rat experiments were previously published by Fernsebner et al. (2014). In brief, 
12 male Sprague-Dawley rats (RjHan:SD) were purchased from Janvier (Janvier S.A.S., 
France). For acclimatization, rats were maintained in standard cages with air filter hoods and 
free access to food and water. Subsequently, animals were divided in two groups: control 
group (n=6) received a standard diet with 23 mg/kg fodder without Mn whereas the treated 
group received Mn-enriched fodder (500 mg/kg body weight, n=6). The whole experiment 
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lasted 53 days, thereafter euthanasia was performed by perforating the aorta abdominals 
suprarenalis after deep narcotization. The brains were snap frozen immediately in liquid 
nitrogen until sample preparation and stored at −80°C. Exactly the same animal brains were 
used for western blot experiments in this current study. All performed rat experiments were 
in accordance with the institutional Animal Welfare Committee as well as approved by the 
Bavarian federal state government under the file number 55.2–1-54–2531-180–12. During 
all animal experiments, operators were skilled and carefully cared for all rodents, giving 
them plenty of food and water and a good feeding environment. No other drugs were used 
except for anesthesia before the tissue was taken. No animals were excluded based on the 
exclusion criteria (abnormal coat color, obvious movement disorders or limb damage).
Statistical analysis:
All statistical analyses were performed using GraphPad Prism Software (GraphPad Software 
Inc.). Normality of Data was carried out by Shapiro-Wilk test before all statistical tests. 
Differences between treatment groups were evaluated using unpaired t-test, one- or two-way 
ANOVA followed by Bonferroni post-hoc analysis. No test for outlier was conducted on the 
data. Data are presented as mean ± SD. A p-value < 0.05 was considered as significant.
RESULTS
Manganese reduces cell viability in a concentration and time-dependent fashion.
The dopaminergic neuroblastoma cell line SH-SY5Y was exposed to increasing 
concentrations of Mn for up to 48 h. Cell viability analysis after 24 h incubation revealed an 
IC50 of ~175 µM, while prolonged treatment after 48 h showed a more pronounced decrease 
in cellular viability with an IC50 of less than ~10 µM Mn. When administering 100 µM of 
Mn for 24 h, we detected in SH-SY5Y cells a viability drop of 36.6 ± 3.5% for 24 h, and 
82.3 ± 6.8 % for 48 h that even further decreased to 89.0 ± 2.5% for 72 h (data not shown) 
(Fig. 1a). In a similar fashion, cell counting data via hemocytometer revealed that cells 
stopped growing, closely reflecting cell viability measurements (Fig. 1b).
Manganese acutely reduces protein levels of neuroprotective iron homeostatic gene 
products APP and H-Ferritin.
We previously reported that the xenobiotic metal lead caused a translational repression of 
APP and H-Ferritin in SH-SY5Y cells (Rogers et al. 2016). Based on this, we evaluated Mn-
dose responsive effects in the range of 10–100 µM and analyzed protein expression of the 
iron homeostatic gene products APP and H-Ferritin. Indeed, Mn led to a significant decrease 
in expression of both proteins after 24 h exposure (Fig. 1c). At 100 µM of Mn, where cell 
viability was decreased by only ~37%, we observed a marked reduction of H-Ferritin (~92.3 
± 10.9%) and APP levels (~82.6 ± 10.8 %) compared to untreated controls, suggesting that 
the effects of Mn on these proteins was not an artifact of immediate cell toxicity. In contrast, 
FAC treatment strongly increased the protein expression of APP and H-Ferritin, underlining 
the iron-responsive nature of both proteins (Cho et al. 2010, Rogers et al. 2002) (Fig. 1d). In 
agreement, time course experiment revealed that Mn limited steady-state APP and H-Ferritin 
protein levels beginning at 6 h after metal exposure in a directly opposing pattern to the 
inductive response after FAC exposure (Fig. 2a,b).
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Manganese-dependent transcriptional response of APP and H-Ferritin does not reflect 
protein changes.
To determine if differential regulation of iron homeostasis genes occurs at the transcriptional 
level, we performed quantitative real-time PCR (qRT-PCR) to measure the mRNA levels of 
APP, H-Ferritin, transferrin receptor 1 (TFR1) and ferroportin (FPN1). Interestingly, 24 h 
treatment with Mn resulted in a more than 3-fold increase of APP mRNA, while mRNA 
levels of H-Ferritin remained nearly unaltered. Moreover, Mn caused a strong induction of 
TFR1 mRNA without affecting FPN1 mRNA levels. In contrast, FAC administration did not 
result in marked changes of any mRNA levels tested (Fig. 2c). As a positive control, we 
treated SH-SY5Y cells with the iron chelator deferoxamine (DFO), resulting in a more than 
eight-fold increment of TFR1 mRNA levels and a suppression of FPN mRNA levels, 
underlining a cellular iron-deficient state (Supplemental Fig. 1).
These results demonstrated a clear discrepancy between protein and mRNA after Mn and 
FAC exposure, suggesting the involvement of post-transcriptional gene regulatory 
mechanisms of APP and H-Ferritin.
Manganese post-transcriptionally blocks 5’-UTR-mediated translation of APP and H-
Ferritin
We first conducted alignments of the equivalent 5’-untranslated regions (5’-UTRs) in the 
transcripts for the human, mouse and rat APP transcripts, the Ferritin-L and –H chains 
mRNAs and also the putative 5’-UTR specific iron specific element (IRE) in the human FPN 
mRNA (Supplemental Fig. 2). We identified a putative IRE stem loop in the 5’-UTR of the 
APP mRNA, based on its similarity to the canonical IRE loops found in H- and L-chain 
Ferritin (Rogers et al. 2002, Thomson et al. 2005). Application of NCBI align showed that 
these 5’-UTR structures align in such a way as to generate characteristic AGA or AGU tri-
loops that can mediate binding to the iron regulatory proteins IRP1 and IRP2 (Cho et al. 
2010, Goforth et al. 2010, Ke et al. 1998).
Based on this finding, we next used SH-SY5Y cells expressing a luciferase (luc) reporter 
fused to the 146-nucleotide 5’-UTR sequence of the APP mRNA (APP 5’-UTR-luc) that we 
previously established to discover APP 5’-UTR-directed compounds (Bandyopadhyay et al. 
2006) and iron responsiveness (Rogers et al. 2002). Compared to the control pGL3-luc 
empty plasmid, 50 µM FAC resulted in a significant increase of APP 5’-UTR-luc activity. 
By contrast, Mn treatment suppressed APP 5’-UTR specific activity by >50% at 50 µM, 
while not significantly affecting pGL3-luc activity (Fig. 3a). We next utilized an H-Ferritin 
IRE-CAT reporter system to monitor the 5’-UTR activity of H-Ferritin mRNA. Similar to 
the 5’-UTR present in APPmRNA, 24 h FAC treatment significantly induced CAT reporter 
activity, while Mn exposure resulted in a significant suppression of H-Ferritin 5’-UTR 
activity (Fig. 3b). IRPs are central post-transcriptional regulators that bind to the 5’-UTR-
IRE regions of both proteins blocking their ribosomal protein translation. We observed that 
Mn promoted the proteolysis of IRP2 while leaving IRP1 protein levels unchanged (Fig. 3c).
In conclusion, our data show that Mn exposure stabilized IRP1 protein levels that may 
potentially still be bound to the 5’-UTR-IREs of APP and H-Ferritin, providing an 
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explanation for suppressed 5’-UTR activities of these genes and subsequent inhibition of 
their endogenous protein translation.
Manganese increases intracellular labile iron pool (LIP) and oxidative stress levels.
APP and H-Ferritin play key roles in export and storage of excess toxic redox active ferrous 
iron (Fe2+). Therefore, we asked if Mn treatment causes changes in Fe2+ levels that represent 
the cellular labile iron pool (LIP). We first used the established calcein-AM assay to measure 
levels of cytosolic redox-active Fe2+ in the labile iron pool (LIP). Calcein is a fluorochrome 
that chelates free Fe2+ under quenching its green calcein fluorescence (Tenopoulou et al. 
2007). Mn exposure to SH-SY5Y cells resulted in a concentration- and time-dependent 
decrease of calcein fluorescence. However, cell-free analysis using DMEM media with 
increasing Mn doses resulted even in a stronger concentration-dependent quenching of 
calcein fluorescence, indicating the limitation of this assay to specifically determine LIP 
alterations (Supplemental Fig. 3a). We therefore utilized two first-generation activity-based 
“turn-on” probes that are capable of selectively detecting Fe2+ over other biologically 
relevant metals including Mn (Aron et al. 2018). RhoNox-1 interacts with Fe2+ resulting in 
the release of fluorescent rhodamine and was recently reported to selectively detect 
endogenous changes in LIP of lung carcinoma cells (Adachi et al. 2016, Niwa et al. 2014), 
while IP-1 relies on an oxygen-dependent, three-component sensing mechanism to detect 
Fe2+ (Au-Yeung et al. 2013). Indeed, we could detect a significant concentration-dependent 
increase in RhoNox-1 and IP-1 fluorescence in SH-SY5Y cells (Fig. 4a), while no 
significant changes could be detected with both dyes in a cell-free environment 
(Supplemental Fig. 3b). Moreover, subsequent 1-h incubation with 100 µM of the iron 
chelator deferiprone (DEF) completely rescued RhoNox-1 and IP-1 fluorescence, 
confirming Mn-mediated intracellular Fe2+ accumulation in SH-SY5Y cells (Fig. 4a). We 
further validated the Mn-induced shift in Fe2+/Fe3+ ratio using IC-ICP-MS and CE-ICP-MS, 
two methods that enable the clear distinction and quantification of iron in both redox-states 
(Fig. 4b and Supplemental Fig. 3c).
Based on this finding, we next examined the induction of oxidative stress using DCF and 
BODIPY 581/591 C11 fluorescence to assess cellular and lipid ROS, respectively. In support 
of a model of disturbed cellular redox homeostasis, Mn significantly increased cellular and 
lipid-ROS levels in a concentration and time-dependent fashion (Fig. 4c-f).
Our results supported previous observations by demonstrating that Mn exposure alters the 
Fe3+/Fe2+ towards redox-active Fe2+, leading to cytoplasmic and lipid ROS generation 
(Fernsebner et al. 2014, Neth et al. 2015, Kwik-Uribe et al. 2003).
Forced expression of APP confers cellular resistance to Mn-induced toxicity.
Since Mn represses endogenous APP translation, we next asked if forced expression of APP 
driven by a CMV (cytomegalovirus) promoter can modify Mn-induced neurotoxicity. We 
therefore utilized SH-SY5Y cells stably overexpressing the neuronal APP695-isoform 
(Venkataramani et al. 2010). In line with the iron-exporting function of APP via FPN 
stabilization (Duce et al. 2010, Wong et al. 2014, McCarthy et al. 2014), SH-SY5Y APP695 
cells had markedly suppressed basal levels of H-Ferritin as well as lowered levels of cellular 
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and lipid ROS compared to controls (Fig. 5a,c). Mn reduced endogenous APP level in mock-
transfected cells while not affecting APP expression level in constitutively overexpressing 
APP695 cells, in support of our previous data. Furthermore, while 50 µM Mn treatment 
caused a complete depletion of H-Ferritin levels in mock-transfected controls, similar 
treatment resulted in only a slight decrease of H-Ferritin levels in APP695 cells (Fig. 5a). 
Consistently, Mn-induced generation of cytoplasmic and lipid ROS was significantly 
suppressed in APP695 overexpressing cells compared to control cells (Fig. 5b). Moreover, 
forced expression of APP695 in SH-SY5Y cells partially promoted cell survival against dose-
responsive Mn-toxicity relative to mock-transfected counterparts (Fig. 5d). Similarly, APP-
wild type (APP+/+) mouse embryonic fibroblasts (MEFs) exhibited a greater resistance to 
Mn toxicity compared to APP−/− MEFs. Notably, FAC pre-treatment resulted in a significant 
protection from Mn toxicity in APP+/+ MEFs, while in Mn-sensitive APP−/− MFEs FAC 
presented no protective effect (Supplemental Fig. 4).
In conclusion, these data support a model that suggests that APP expression abrogates Mn-
induced oxidative stress and cell toxicity and, that FAC pre-treatment in MEFs could 
partially reverse Mn toxicity in an APP-dependent manner.
Mn treatment reduces brain cortex APP and H-Ferritin levels in two in vivo models.
To examine the in vivo relevance of Mn-mediated APP and H-Ferritin suppression we fed 
male C57BL/6N mice with either a normal (10 p.p.m Mn) or high Mn diet (2400 p.p.m Mn), 
doses that do not induce toxicity in mice (Sato et al. 1996). After 91 days of chronic Mn 
exposure we observed a significant reduction of APP and H-Ferritin expression in brain 
tissue lysates of high Mn fed mice compared to standard dietary fed controls (Fig. 6a,b). To 
evaluate the effects of acute Mn exposure, we intraperitoneally (i.p.) administered male 
C57BL/6N mice with either Mn (40 mg/kg body weight/day) or PBS (control) for 7 days. 
Consistently, we observed suppressed levels of APP and H-Ferritin protein expression in 
Mn-treated mice compared to controls (Fig. 6 c,d). We validated these in vivo findings in 
brain lysates that we obtained from a previous published Mn study from Fernsebner et al. 
(2014) in which male Sprague-Dawley rats were either orally challenged with Mn 
(500mg/kg body weight) or standard diet (control) for 53 days. Re-evaluation of these total 
brain extracts clearly demonstrated that Mn treatment resulted in a marked suppression of 
APP and H-Ferritin protein levels compared to control-treated rats (Fig. 6e,f). In agreement 
with our in vitro findings, we observed in Mn-treated rat brains reduced protein levels of 
IRP2, while IRP1 expression levels were unaltered (Supplemental Fig. 5 a,b).
In conclusion, we validated our in vitro data in two independent in vivo rodent models. 
Chronic and acute administration of Mn clearly resulted in suppressed protein expression of 
APP and H-Ferritin compared to respective controls.
DISCUSSION
Chronic environmental exposure to Mn results in its excessive accumulation in iron-rich 
brain regions such as the basal ganglia resulting in dystonic neurodegenerative movement 
disorders that resemble features of PD and PD-like syndromes (Pal et al. 1999, Chia et al. 
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1993, Guilarte 2013, Gorell et al. 1997). However, the primary mechanism(s) that drives and 
propagates Mn-induced neurotoxicity remains to be established.
Our study demonstrates for the first time that Mn simultaneously suppresses protein 
expression of APP and H-Ferritin in vitro and two independent in vivo settings. 
Mechanistically, the repression of APP and H-Ferritin is in part mediated post-
transcriptionally via blocking the conserved 5’-UTR-dependent regions of their mRNA 
transcripts. We propose that this Mn-induced translational block is achieved by increased 
binding of IRP1 to the IRE sequences within the 5’-UTR of APP and H-Ferritin (see 
schematic model in Figure 7). Indeed, under iron-depleted conditions when aconitase loses 
its labile Fe2+ and thus converts to IRP1, the coordination chemistry of Mn closely 
resembles that of Fe2+, possibly allowing Mn to interact with Fe2+ in aconitase/IRP1 and 
altering its function (Zheng et al. 1998). Recently, comparative analysis of kinetic and 
thermodynamic properties of IRP1 showed that Mn results in a 12-fold increase of IRE-
mRNA/IRP1 binding, while Fe2+ decreases the interaction between IRP1 and IRE sequences 
(Khan et al. 2017). As part of a physiological reaction, iron treatment (in the form of FAC) is 
tightly regulated to avoid free generation of toxic Fe2+. Iron exposure results in the release 
of IRPs from IRE-containing mRNAs, enhancing the coordinated translation of iron-related 
genes (Bogdan et al. 2016). Consistently, we observed that FAC treatment in neuronal cells 
resulted in a concentration- and time-dependent induction of the iron storage protein H-
Ferritin and APP that facilitates the stability of membrane-bound FPN, each capable in 
reducing the amount of intracellular toxic redox-active Fe2+ (Duce et al. 2010, Wong et al. 
2014, McCarthy et al. 2014). Conversely, we could demonstrate that Mn-mediated 
suppression of APP and H-Ferritin resulted in an increase of free Fe2+, accelerating toxic 
cytoplasmic and lipid ROS accumulation (Figure 7). Recently, Tai et al. demonstrated that 
low millimolar doses of Mn resulted in increased autophagic ferritin degradation also known 
as ferritinophagy (Tai et al. 2016). In this regard, we tested alteration of autophagy markers 
LC3B and Beclin-1 and observed no marked induction of both autophagy markers in Mn-
treated rat brains compared to controls, thus suggesting that autophagic ferritin degradation 
is unlikely to explain our findings in our in vivo setting (Supplemental Fig. 5 b,c).
We furthermore demonstrated that forced expression of APP suppressed Mn-mediated toxic 
cytoplasmic ROS and lipidperoxidation generation and even partially rescued cellular 
toxicity. Moreover, FAC pretreatment could partially rescue increased Mn toxicity in 
wildtype APP+/+ MEFs, while a similar FAC pretreatment presented no such significant 
protective effects in APP−/− cells, altogether underlining the integral involvement of APP as 
a neuroprotective and iron homeostatic gene product capable in attenuating Mn toxicity.
In summary, Mn-altered IRP1/IRE-binding affinity coordinates the translational suppression 
of neuroprotective APP and H-Ferritin that in turn leads to a profound increase of redox-
active iron, providing a more complete explanation of the Mn-induced shift in the Fe2+/Fe3+ 
ratio and neurotoxic oxidative stress accumulation that we and others previously observed in 
vitro and in vivo (Fernsebner et al. 2014, Kwik-Uribe et al. 2003, Neth et al. 2015).
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Figure 1. Opposing effects of Mn and FAC exposure to cell viability and protein expression of 
APP and H-Ferritin in human neuroblastoma cells.
Human SH-SY5Y cells were incubated with increasing Mn concentrations for 24 h and 48 h 
and analyzed for (a) cell viability (n=3) and (b) cell number (24 h, n=6; 48 h, n=4). (c) Cell 
lysates of control and Mn treated SH-SY5Y cells were separated on 4-12% Bis-Tris gels. 
Western blot and densitometric quantification of APP (clone A8717) and H-Ferritin (clone 
D1D4) (n=3). (d) SH-SY5Y cells treated with increasing FAC concentrations for 24 h, 
immunoblotted for APP (clone A8717) and H-Ferritin (clone D1D4). Densitometric 
quantification of both proteins were adjusted to loading control β-actin (n=3). Data shown 
represent mean ± SD. N number indicates number of replicates. Differences were calculated 
using either one-way ANOVA followed by Bonferroni post hoc analyses (a, b) or unpaired t-
test (c, d) (*, p < 0.05; **, p < 0.01; ***, p < 0.001).
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Figure 2. Acute exposures of Mn and FAC differentially impacts protein and mRNA levels of 
APP and H-Ferritin.
(a) SH-SY5Y cells treated with 100 µM Mn for indicated time points and immunoblotted for 
APP (clone 22C11) and H-Ferritin (clone D1D4). All densitometric analyses were 
standardized to corresponding β-actin levels (n=3). (b) SH-SY5Y cells were incubated with 
100 µM FAC for indicated time points and immunoblotted for APP (clone 22C11) and H-
Ferritin (clone D1D4). All densitometric analyses were standardized to corresponding β-
actin levels (n=3). (c) RT-PCR analysis of indicated iron responsive target genes (APP, H-
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Ferritin, TFR1 and FPN) from SH-SY5Y cells incubated for 24 h with 100 µM FAC or 
100µM Mn. All data are normalized to housekeeping gene β-actin and presented as relative 
fold-induction compared to untreated controls (n=4). RT-PCR analysis of DFO-treated SH-
SY5Y cells were shown in Supplemental Fig 1. Data shown represent mean ± SD. N number 
indicates number of replicates. Differences were calculated using unpaired t-test (*, p < 
0.05; **, p < 0.01; ***, p < 0.001).
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Figure 3: The effect of Mn and FAC on IRE/IRP-dependent expression of APP and H-Ferritin.
(a) SH-SY5Y cells transfected with the pGL3 construct expressing the 146-nucleotide APP 
5’UTR sequence (APP 5’-UTR) or empty plasmid (pGL3) were left untreated (Ctrl) or 
exposed to either 50 µM Mn (n=7) or 50 µM FAC (n=4) for 24 h and analyzed for luciferase 
activity. Data are depicted as relative luciferase activity compared to untreated controls. (b) 
In a similar fashion, SH-SY5Y cells were transfected with the HIRE-CAT construct (H-
Ferritin 5’-UTR) and treated with either 50 µM Mn or 50 µM FAC for 24 h or left untreated 
(Ctrl) and analyzed for CAT (chloramphenicol acetyltransferase) reporter activity using an 
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enzyme-linked immunosorbent assay (n=4). (c) Immunoblot analysis of Iron-regulatory 
protein-1 (IRP1) and IRP2 protein expression in response to increasing Mn concentrations. 
β-actin served as loading control (n=3). Data shown represent mean ± SD. N number 
indicates number of replicates. Differences were calculated using two-way ANOVA (a) or 
unpaired t-test (b, c) (*, p < 0.05; **, p < 0.01).
Venkataramani et al. Page 22
J Neurochem. Author manuscript; available in PMC 2019 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4. Mn treatment increases labile iron pool (LIP), cytoplasmic and lipid ROS levels in a 
concentration and time-dependent manner.
(a) SH-SY5Y cells were incubated for 24 h with indicated Mn concentrations and incubated 
with either 5 µM RhoNox-1 dye for 1 h (left panel) or 20 µM IP-1dye for 2h (right panel). 
As additional control Mn treated wells were incubated with 100 µM of the iron chelator 
Deferiprone (DEF) for 1 h and incubated with both dyes. Fluorescence was presented as 
absolute fluorescence units (F.U.) (n=6). Cell-free fluorescence intensities of both Fe2+-
selective dyes ± 100 µM Mn in OpiMEM were shown in Supplemental Fig. 3b. (b) IC-ICP-
MS and CE-ICP-MS analysis were performed to determine Fe3+ and Fe2+ levels in RIPA 
lysates from SH-SY5Y incubated with DMEM media alone or 100 µM Mn for 24 h. Data 
are presented as Fe3+ and Fe2+ to total iron (Fe3+ and Fe2+) ratio (n=3). Absolute Fe3+ and 
Fe2+ values are presented in Supplemental Fig. 3c. (c) SH-SY5Y cells treated with 
increasing Mn concentrations for 24 h and analyzed for cellular oxidative stress levels via 
DCF fluorescence using flow cytometry. Mean relative fluorescence intensity (RFI) was 
presented as % increase to untreated controls (n=3). (d) SH-SY5Y cells treated with 100 µM 
Mn for indicated time points and analyzed for DCF fluorescence (n=3). (e) In a similar 
fashion lipid ROS was determined using the fluorescence dye BODIPY-C11 and flow 
cytometry after Mn treatment with increasing concentrations for 24 h (f) or 100 µM Mn for 
indicated time points. Mean relative fluorescence intensity of DCF and FL1/FL2 ratio of 
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BODIPY-C11 were presented as % increase to untreated controls (n=3). Data shown 
represent mean ± SD. N number indicates number of replicates. Differences were calculated 
using unpaired t-test (*, p < 0.05; **, p < 0.01).
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Figure 5: APP over-expression protects against Mn-induced toxicity via attenuating oxidative 
stress.
(a) Representative histogram of cellular ROS (left panel) and lipid ROS (right panel) levels 
of SH-SY5Y cells, either stably overexpressing the APP695-isoform (APP695) or with the 
empty vector pCEP4 (Mock). (b) SH-SY5Y Mock and APP695 cells were exposed to Mn for 
24 h and analyzed for cellular oxidative cells via DCF dye (left panel) or lipid-ROS using 
BODIPY-C11 (right panel). DCF fluorescence is presented as arbitrary fluorescence units 
(F.U) (n=3). Lipid-ROS data are presented as FL1/FL2 ratio (n=3). (c) Mock and APP695-
transfected SH-SY5Y cells were incubated with increasing Mn concentrations for 24 h and 
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analyzed for APP (clone 22C11) and H-Ferritin (clone D1D4) protein expression. (d) Cell 
viability was analyzed in Mock and APP695-expressing SH-SY5Y cells after Mn exposure 
for 24 h (n=3). All other data are presented as mean ± SD. N number indicates number of 
replicates. Differences were calculated using two-way ANOVA (*, p < 0.05; **, p < 0.01; 
***,p < 0.001).
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Figure 6: Dietary Mn suppresses APP and H-Ferritin protein expression in vivo and inversely 
correlates with redox-active Fe2+ levels.
(a) Mice were orally treated with standard diet (control group: 10 p.p.m Mn) or high Mn diet 
(Mn group: 2400 p.p.m Mn) for 91 days. (b) Explanted cortices were analyzed for APP 
(clone A8717) and H-Ferritin (ab137758). β-actin (clone AC-15) served as loading control. 
(c) Relative protein levels were measured by densitometry and normalized to β-actin (each 
group: n=5). (d) Mice were either i.p. injected with PBS (control group) or with MnCl2 (40 
mg/kg/day) for 7 days. (e) Cortices were blotted for APP (clone A8717) and H-Ferritin 
(ab137758). β-actin served as loading control. (f) Relative protein levels were measured by 
densitometry and normalized to β-actin (each group: n=5). (g) Sprague-Dawley rats were 
orally treatment with Mn (500 mg/kg) or with standard diet for 53 days. (h) Harvested 
whole brain lysates were blotted for rat APP (clone 22C11) and H-Ferritin (clone D1D4). β-
actin served as loading control. (i) Densitometric quantification of APP and H-Ferritin were 
normalized to β-actin (each group: n=6). Representative western blots of IRP1, IRP2, 
Beclin-1 and LC3 are shown in Supplemental Fig. 5. Data are presented as mean ± SD. N 
number indicates number of individual animals. Differences were calculated by unpaired t-
test (*, p<0.05; **, p<0.01).
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Figure 7: Proposed model for Mn-induced neurotoxicity.
(a) Under physiological conditions, free ferrous iron (Fe2+) causes IRP1 release from iron 
responsive elements (IRE) that are located within the 5’-untranslated regions (5’-UTRs) of 
APP and H-Ferritin mRNA inducing enhanced ribosomal protein translation. To counteract 
toxic redox-active Fe2+ levels, APP facilitates the stabilization of membrane-bound Fe2+-
exporter ferroportin (FPN) while H-Ferritin safely sequesters Fe2+ via conversion to redox-
inactive Fe3+. (b) Manganese (Mn) decreases APP and H-Ferritin protein translation by 
increasing the binding of IRP1 to the IRE on the 5’-UTR of APP and H-Ferritin mRNA. 
Translational blockage of APP and H-Ferritin results in accumulation of toxic Fe2+ that fuels 
the generation of reactive oxygen species (ROS), ultimately resulting in neurotoxicity.
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